Regulation of mu binding sites after chronic administration of antibodies directed against specific anti-opiate peptides. (Q48311272)

10 February 2018

title

Regulation of mu binding sites after chronic administration of antibodies directed against specific anti-opiate peptides. (English)

1 reference

10 February 2018

1 reference

Goodman CB

1

1 reference

10 February 2018

Heyliger S

2

1 reference

10 February 2018

Emilien B

3

1 reference

10 February 2018

Partilla JS

4

1 reference

10 February 2018

Yang HY

5

1 reference

10 February 2018

Lee CH

6

1 reference

10 February 2018

Cadet JL

7

1 reference

10 February 2018

Rothman RB

8

1 reference

10 February 2018

publication date

1 January 1998

1 reference

10 February 2018

published in

Peptides

1 reference

10 February 2018

volume

19

1 reference

10 February 2018

issue

10

1 reference

10 February 2018

page(s)

1703-1709

1 reference

10 February 2018

Melanocortins and opiate addiction

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Opioid and anti-opioid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Specific receptor for the opioid peptide dynorphin: structure--activity relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Characterization and solubilization of the FMRFamide receptor of squid

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Effect of prolyl-leucyl-glycinamide and α-melanocyte-stimulating hormone on levorphanol-induced analgesia, tolerance and dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Dynorphin: a possible modulatory peptide on morphine or beta-endorphin analgesia in mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Spinal dynorphin A (1-17): possible mediator of antianalgesic action

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Downregulation of mu-opioid binding sites following chronic administration of neuropeptide FF (NPFF) and morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Mismatches between neurotransmitter and receptor localizations in brain: observations and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

IgG from antiserum against endogenous mammalian FMRF-NH2-related peptides augments morphine- and stress-induced analgesia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Central neuronal pathways containing FLFQPQRFamide-like (morphine-modulating) peptides in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Opiate and peptide interaction: Effect of enkephalins on morphine analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Distribution and characterization of two putative endogenous opioid antagonist peptides in bovine brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Effects of immunoneutralization of dynorphin1-17 and dynorphin1-8 on the activity of central dopaminergic neurons in the male rat

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

FMRF-NH2-like mammalian octapeptide: possible role in opiate dependence and abstinence.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Analog of neuropeptide FF attenuates morphine abstinence syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Autoradiographic localization of mu- and delta-opiate receptors in the forebrain of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

mu-Opposing actions of the kappa-opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Modulation of neuropeptide FF receptors by guanine nucleotides and cations in membranes of rat brain and spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Peptide E and other proenkephalin-derived peptides are potent kappa opiate receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

A review of the role of anti-opioid peptides in morphine tolerance and dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Cholecystokinin-8 suppressed 3H-etorphine binding to rat brain opiate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

Interactions of Tyr-MIF-1 at opiate receptor sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900121-1

7 January 2021

10.1016/S0196-9781(98)00121-1

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018